NCT06609200 Electro-Acupuncture for Obese Patients With Insulin Resistance
| NCT ID | NCT06609200 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanyang Technological University |
| Condition | Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-10-10 |
| Primary Completion | 2026-04-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-10-10 with a primary completion date of 2026-04-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial aims to evaluate the efficacy and safety of electro-acupuncture for obese patients with insulin resistance. 60 participants will be randomized and allocated to either the electro-acupuncture arm or the sham acupuncture arm.
Eligibility Criteria
Inclusion Criteria: * Men and women aged between 21 and 65 years old * BMI ≥ 25 kg/m2 * HOMA-IR ≥ 2.14, (HOMA-IR = fasting insulin (ųU/mL)\* fasting glucose (mmol/L)/22.5) * Not receiving any other weight control measures or any medical and/or drug history in the last 3 months Exclusion Criteria: * Diabetes mellitus * Treating with drugs that may affect insulin sensitivity * Changes 10% of usual body weight in the previous 6 months weight * Endocrine diseases, including thyroid disorder, pituitary disorder, sex gland disorder, etc. * Heart diseases, including arrhythmia, heart failure, and myocardial infarction, participants with pacemakers * Allergy and immunology diseases * Bleeding tendency * Pregnant or lactating women * Impaired hepatic or renal function * Stroke or unable to exercise
Contact & Investigator
Linda Zhong, Ph.D.
PRINCIPAL INVESTIGATOR
nanyang technological university traditional chinese medicine clinic
Frequently Asked Questions
Who can join the NCT06609200 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 65 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06609200 currently recruiting?
Yes, NCT06609200 is actively recruiting participants. Contact the research team at linda.zhong@ntu.edu.sg for enrollment information.
Where is the NCT06609200 trial being conducted?
This trial is being conducted at Singapore, Singapore.
Who is sponsoring the NCT06609200 clinical trial?
NCT06609200 is sponsored by Nanyang Technological University. The principal investigator is Linda Zhong, Ph.D. at nanyang technological university traditional chinese medicine clinic. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.